Literature DB >> 28298405

A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis.

Angira Dasgupta1, Melanie Kjarsgaard1, Dante Capaldi2, Katherine Radford1, Fernando Aleman1, Colm Boylan3, Leonard C Altman4, Thomas N Wight5, Grace Parraga2, Paul M O'Byrne1, Parameswaran Nair6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28298405     DOI： 10.1183/13993003.02486-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  14 in total

1.  Journal Club-COPD2020 Update. Global Initiative for Chronic Obstructive Lung Disease 2020 Report and the Journal of the COPD Foundation Special Edition, Moving to a New Definition for COPD: "COPDGene® 2019".

Authors:  Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

2.  Anti-IL-5 therapies for chronic obstructive pulmonary disease.

Authors:  Tim Donovan; Stephen J Milan; Ran Wang; Emma Banchoff; Patrick Bradley; Iain Crossingham
Journal:  Cochrane Database Syst Rev       Date:  2020-12-08

3.  Eosinophil-derived IL-13 promotes emphysema.

Authors:  Alfred D Doyle; Manali Mukherjee; William E LeSuer; Tyler B Bittner; Saif M Pasha; Justin J Frere; Joseph L Neely; Jake A Kloeber; Kelly P Shim; Sergei I Ochkur; Terence Ho; Sarah Svenningsen; Benjamin L Wright; Matthew A Rank; James J Lee; Parameswaran Nair; Elizabeth A Jacobsen
Journal:  Eur Respir J       Date:  2019-05-30       Impact factor: 16.671

Review 4.  Anti-IL-5 therapies for asthma.

Authors:  Hugo A Farne; Amanda Wilson; Stephen Milan; Emma Banchoff; Freda Yang; Colin Ve Powell
Journal:  Cochrane Database Syst Rev       Date:  2022-07-12

5.  A systematic review and integrated analysis of biologics that target Type 2 inflammation to treat COPD with increased peripheral blood eosinophils.

Authors:  Hiroshi Ohnishi; Masamitsu Eitoku; Akihito Yokoyama
Journal:  Heliyon       Date:  2022-06-16

Review 6.  Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.

Authors:  Donald P Tashkin; Michael E Wechsler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-17

7.  Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.

Authors:  Michael A Ghebre; Pee Hwee Pang; Sarah Diver; Dhananjay Desai; Mona Bafadhel; Koirobi Haldar; Tatiana Kebadze; Suzanne Cohen; Paul Newbold; Laura Rapley; Joanne Woods; Paul Rugman; Ian D Pavord; Sebastian L Johnston; Michael Barer; Richard D May; Christopher E Brightling
Journal:  J Allergy Clin Immunol       Date:  2018-04-28       Impact factor: 10.793

8.  Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.

Authors:  Annette T Hastie; Fernando J Martinez; Jeffrey L Curtis; Claire M Doerschuk; Nadia N Hansel; Stephanie Christenson; Nirupama Putcha; Victor E Ortega; Xingnan Li; R Graham Barr; Elizabeth E Carretta; David J Couper; Christopher B Cooper; Eric A Hoffman; Richard E Kanner; Eric Kleerup; Wanda K O'Neal; Richard Paine; Stephen P Peters; Neil E Alexis; Prescott G Woodruff; MeiLan K Han; Deborah A Meyers; Eugene R Bleecker
Journal:  Lancet Respir Med       Date:  2017-11-13       Impact factor: 30.700

9.  Sputum Inflammometry to Manage Chronic Obstructive Pulmonary Disease Exacerbations: Beyond Guidelines.

Authors:  Carmen Venegas; Nan Zhao; Terence Ho; Parameswaran Nair
Journal:  Tuberc Respir Dis (Seoul)       Date:  2020-06-18

10.  Asthmatic bronchial epithelial cells promote the establishment of a Hyaluronan-enriched, leukocyte-adhesive extracellular matrix by lung fibroblasts.

Authors:  Stephen R Reeves; Inkyung Kang; Christina K Chan; Kaitlyn A Barrow; Tessa K Kolstad; Maria P White; Steven F Ziegler; Thomas N Wight; Jason S Debley
Journal:  Respir Res       Date:  2018-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.